CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model

Area of Science:

• Immunology
• Cellular Biology

Background:

• T-cell activation is a complex process involving multiple signaling pathways.
• The CD28 receptor and its ligands, B7-1 and B7-2, are critical for costimulation.
• Understanding the precise timing and nature of these interactions is essential for immune modulation.

Purpose of the Study:

• To propose a sequential multiple-step model for T-cell activation.
• To investigate the role of CD28-B7 interactions in T-cell responses.
• To explore novel strategies for immuno-intervention based on T-cell activation mechanisms.

Main Methods:

• In vitro stimulation of human peripheral blood T lymphocytes via CD28 and TCR.
• Utilizing monoclonal antibodies (mAb) or natural ligands (B7-1, B7-2) for stimulation.
• Employing blockade strategies with anti-B7-1, anti-B7-2, and cyclosporine A (CsA).

Main Results:

• CD28 ligation along with TCR stimulation up-regulates T-cell activities, including cytokine secretion and cytotoxic activity.
• CD28-B7 interactions involve various T-cell subsets (CD4+, CD8+, naive, memory).
• Late addition of anti-B7 reagents, unlike anti-LFA-1, can still inhibit T-cell responses, suggesting a late requirement for CD28-B7 interaction.

Conclusions:

• A sequential, multi-step model for T-cell activation is proposed, emphasizing the temporal aspect of CD28-B7 interactions.
• The CD40-CD40L axis may play a role in sustaining B7 expression on antigen-presenting cells (APCs), preventing T-cell anergy.
• These findings provide a basis for designing novel immuno-intervention strategies targeting T-cell activation pathways.